{"nct_id":"NCT03671590","title":"Study of TG-1701, an Irreversible Bruton's Tyrosine Kinase Inhibitor, in Patients With B-Cell Malignancies","status":"TERMINATED","status_verified_date":"2024-07","start_date":"2018-09-10","start_date_type":"ACTUAL","primary_completion_date":"2024-05-21","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-21","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TGTX"]}